Sparton — Merger or Acquisition (February 2013)
8 slides from Sparton's merger presentation, Feb 1, 2013
Slide 1: Onyx Acquisition Update Conference Call
Exhibit 99.1 Onyx Acquisition Update Conference Call February 1, 2012
Slide 2: Safe Harbor Statement
Safe Harbor Statement Certain statements herein constitute forward-looking statements within the meaning of the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended. When used herein, words such as “believe,” “expect,” “anticipate,” “project,” “plan,” “estimate,” “w
Slide 3: Today's Agenda
Today’s Agenda • Strategic Rationale • Financial Discussion • Outlook • Schedules • Q&A 3
Slide 4: Strategic Rationale
Strategic Rationale • Regional expansion into the Minneapolis medical device corridor. • Diversifies our customer base and continues to increase the number of complex sub-assembly and full device programs within Sparton. • Strong business development pipeline. • Sparton’s Viet Nam facility is an via
Slide 5: Financial Discussion
Financial Discussion • $43.25 million purchase price, all-cash transaction • Working capital adjustment of $2.2 million – Should not be included as consideration – Elevated days of working capital at closing: days normalized by 12/31/12 • As of September 30, 2012 – $51 million of revenue at 17% gros
Slide 6: Outlook
Outlook • The Onyx facility has higher gross margins than Sparton’s current medical segment • Estimated annual earnings growth: – $500k-$1,000k in earnings from increased sales growth – $250k-$500k in earnings from yet to be realized operational synergies • Sales backlog at $30.5 million (firm order
Slide 7: Financial Schedules
Financial Schedules Onyx Fiscal TTM Year Ended Ended 11/30/2011 9/30/2012 Sales 52,000 50,680 O.I. 3,711 3,376 O.I. % 7.1% 6.7% Depr 1,149 1,348 EBITDA 4,860 4,724 Add-backs Augustine 745 745 Corp 388 424 1,133 1,169 Adjusted EBITDA 5,993 5,893 11.5% 11.6% Acquisition Price 43,250 43,250 Multiple 7.
Slide 8: Q&A
A) iy SPsrtor Q&A